We are live on ! Find out more
SAM

Symphony Asset Management Portfolio holdings

AUM $309M
1-Year Est. Return 9.39%
This Fund
S&P 500
This Quarter Est. Return
+6.4%
1 Year Est. Return
+9.39%
3 Year Est. Return
+21.56%
5 Year Est. Return
+39.45%
10 Year Est. Return
AUM
$1.37B
AUM Growth
+$378M
Cap. Flow
+$49.4M
Cap. Flow %
3.62%
Top 10 Hldgs %
37.17%
Holding
513
New
154
Increased
110
Reduced
133
Closed
61

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$273M
2
AGN
Allergan plc
AGN
+$7.25M
3
AAPL icon
Apple
AAPL
+$4.69M
4
BKNG icon
Booking.com
BKNG
+$4.65M
5
WHR icon
Whirlpool
WHR
+$4.65M

Sector Composition

Rank Sector Weight
1 Financials 26.54%
2 Consumer Discretionary 6.22%
3 Technology 5.91%
4 Healthcare 5.35%
5 Industrials 5.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSC icon
201
Norfolk Southern
NSC
$78.8B
$712K 0.05%
7,671
-3,623
-32% -$311K
BMRN icon
202
CALL
BioMarin Pharmaceuticals
BMRN
$11.5B
$704K 0.05%
10,000
+2,500
+33% +$170K
IWB icon
203
iShares Russell 1000 ETF
IWB
$47.7B
$701K 0.05%
+6,799
New +$673K
SPG icon
204
Simon Property Group
SPG
$74.5B
$691K 0.05%
4,829
-16,617
-77% -$2.39M
PRE
205
DELISTED
PARTNERRE LTD
PRE
$686K 0.05%
6,508
-3,073
-32% -$302K
EMC
206
DELISTED
EMC CORPORATION
EMC
$682K 0.05%
27,093
-134,416
-83% -$3.26M
NBR icon
207
CALL
Nabors Industries
NBR
$1.23B
$680K 0.05%
+800
New +$677K
MANH icon
208
Manhattan Associates
MANH
$8.97B
$679K 0.05%
23,132
-26,800
-54% -$737K
SNY icon
209
Sanofi
SNY
$104B
$679K 0.05%
+12,651
New +$653K
LBTYA icon
210
Liberty Global Class A
LBTYA
$3.31B
$669K 0.05%
18,236
+4,625
+34% +$155K
RDS.B
211
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$659K 0.05%
+8,780
New +$618K
TEVA icon
212
Teva Pharmaceuticals
TEVA
$35.9B
$643K 0.05%
+16,028
New +$631K
PETM
213
DELISTED
PETSMART INC
PETM
$643K 0.05%
8,832
-193
-2% -$14.1K
AEL
214
DELISTED
American Equity Investment Life Holding Company
AEL
$641K 0.05%
24,294
-18,221
-43% -$415K
RNR icon
215
RenaissanceRe
RNR
$13.7B
$634K 0.05%
+6,509
New +$606K
TK icon
216
Teekay
TK
$975M
$633K 0.05%
+13,186
New +$578K
UL icon
217
Unilever
UL
$131B
$625K 0.05%
+13,484
New +$603K
KEY icon
218
KeyCorp
KEY
$24.3B
$621K 0.05%
+46,253
New +$585K
PSX icon
219
Phillips 66
PSX
$82.9B
$612K 0.04%
7,928
-9,741
-55% -$650K
MDT icon
220
Medtronic
MDT
$107B
$605K 0.04%
10,526
-4,866
-32% -$276K
UPS icon
221
United Parcel Service
UPS
$97.6B
$605K 0.04%
+5,758
New +$567K
NVS icon
222
Novartis
NVS
$295B
$601K 0.04%
+8,348
New +$580K
PBH icon
223
Prestige Consumer Healthcare
PBH
$2.35B
$589K 0.04%
16,456
-19,287
-54% -$640K
PNW icon
224
Pinnacle West Capital
PNW
$12.9B
$584K 0.04%
11,040
+276
+3% +$15.1K
JNJ icon
225
Johnson & Johnson
JNJ
$635B
$580K 0.04%
6,326
-18,749
-75% -$1.73M

Similar funds

Symphony Asset Management's Q4 2013 Portfolio in Review

As of Q4 2013, Symphony Asset Management held 513 positions worth $1.37B, up 38% from $988M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Symphony Asset Management deployed $49.4M of net new capital in Q4 2013, opening 154 new positions and adding to 110 existing holdings. Its largest new stake was Allergan plc: 46,358 shares worth $7.79M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 6.9% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was EMC CORPORATION, an estimated $3.26M trimmed.

  • Symphony Asset Management's largest Q4 2013 buy was Allergan plc: 46,358 shares worth $7.79M.
  • Symphony Asset Management added most to Citigroup in Q4 2013, an estimated $273M increase.
  • Symphony Asset Management's biggest Q4 2013 reduction was EMC CORPORATION, cutting an estimated $3.26M.
  • Symphony Asset Management fully exited Elevance Health in Q4 2013, selling an estimated $11.6M.
  • Symphony Asset Management's ten largest holdings make up 37% of its $1.37B portfolio in Q4 2013.
  • Symphony Asset Management opened 154 new positions and closed 61 in Q4 2013.
  • Symphony Asset Management's portfolio value rose 38% quarter-over-quarter to $1.37B.

Based on Symphony Asset Management's 13F filing for Q4 2013, filed 11 Feb 2014.